SoftBank Group Corp. is in discussions to invest in API Holdings Pvt, which owns India’s largest online pharmacy chain Pharmeasy, according to people familiar with the matter. API is seeking a valuation of at least $5.6...
Sweden’s Vitrolife to buy Igenomix in EUR 1.25 billion deal
Swedish medical technology group Vitrolife said on Thursday it would buy reproductive genetic testing services provider Igenomix S.L. in a deal worth 1.25 billion euros ($1.48 billion) on a cash and debt-free basis. The...
Ramsay Health sweetens offer for Britain’s Spire to win over investors
Australia’s Ramsay Health Care has raised its offer to buy British peer Spire Healthcare to about 1.04 billion pounds ($1.44 billion), the hospital operators said on Monday after reports of some investor opposition to a...
Quadria to pick stake in Encube
Healthcare focused private equity firm Quadria Capital along with its co-investors, including Gulf Islamic Investments, has committed over $100 million for a minority stake in Encube Ethicals, a manufacturer of topical...
PharmEasy to pick up 66.1% stake in Thyrocare for Rs 4,546 crore
Online medicine delivery firm PharmEasy on Friday announced that its parent API Holdings Ltd (API) will acquire 66.1 per cent stake in Thyrocare for Rs 4,546 crore from Dr A Velumani and affiliates. Thyrocare is the...
CD&R poised to sweeten UDG take-private bid after investor opposition
Private equity firm Clayton, Dubilier & Rice (CD&R) could increase its offer for UDG Healthcare to 2.72 billion pounds ($3.79 billion), the London-listed group said on Friday, following shareholder opposition to...
SoftBank-backed Pear Therapeutics agrees $1.6 billion SPAC deal
SoftBank-backed healthcare startup Pear Therapeutics has agreed to go public through a merger with Thimble Point Acquisition Corp, a blank cheque company affiliated with an heir of the Pritzker family, creating a...
Cadila Healthcare and Bayer to extend JV partnership for three years
Cadila Healthcare and Bayer (South East Asia) on Monday said that they have decided to extend the operations of their joint venture by three years with effect from June. The companies had entered into an agreement on...
Exclusive: Suburban Diagnostics in sale talks with Dr Lal Pathlabs, Metropolis, PharmEasy, others
Pathology services provider Suburban Diagnostics is in talks with Dr. Lal PathLabs, Metropolis Healthcare, PharmEasy, and a clutch of private equity funds for a complete sale said people close to the development. The...
EU antitrust regulators set July 27 deadline for Illumina, Grail deal
EU antitrust regulators will rule by July 27 whether to clear Illumina Inc’s proposed $7.1 billion acquisition of cancer test maker Grail Inc, a European Commission filing showed on Thursday. U.S. life sciences company...
Danaher to buy Moderna supplier Aldevron for about $9.6 billion
Medical equipment maker Danaher Corp said on Thursday it would buy privately held biotech company Aldevron in an all-cash deal for about $9.6 billion, snapping up a supplier to COVID-19 vaccine maker Moderna Inc. U.S...
1Life Healthcare to buy Iora Health in deal valued at $2.1 billion
Digital health provider 1Life Healthcare Inc said on Monday it would acquire privately-held Iora Health in an all-stock transaction valued at about $2.1 billion to benefit from its Medicare Advantage members...
